Liver Biology/Pathobiology

Bile duct proliferation inJag1/fringe heterozygous mice identifies candidate modifiers of the alagille syndrome hepatic phenotype

Ryan, Matthew J.1,4; Bales, Christina1; Nelson, Anthony1; Gonzalez, Dorian M.2; Underkoffler, Lara1; Segalov, Michelle2; Wilson-Rawls, Jeanne5,6; Cole, Susan E.7; Moran, Jennifer L.8; Russo, Pierre3,4; Spinner, Nancy B.2,3,4; Kusumi, Kenro2,4,5,6; Loomes, Kathleen M.1,4*

Author Information
Hepatology 48(6):p 1989-1997, December 2008. | DOI: 10.1002/hep.22538

Abstract

Alagille syndrome (AGS) is a heterogeneous developmental disorder associated with bile duct paucity and various organ anomalies. The syndrome is caused by mutations inJAG1, which encodes a ligand in the Notch signaling pathway, in the majority of cases and mutations in theNOTCH2receptor gene in less than 1% of patients. Although a wide array ofJAG1mutations have been identified in the AGS population, these mutational variants have not accounted for the wide phenotypic variability observed in patients with this syndrome. The Fringe genes encode glycosyltransferases, which modify Notch and alter ligand-receptor affinity. In this study, we analyzed double heterozygous mouse models to examine the Fringe genes as potential modifiers of the Notch-mediated hepatic phenotype observed in AGS. We generated mice that were haploinsufficient for bothJag1and one of three paralogous Fringe genes: Lunatic (Lfng), Radical (Rfng), and Manic (Mfng). AdultJag1+/−Lfng+/− andJag1+/−Rfng+/− mouse livers exhibited widespread bile duct proliferation beginning at 5 weeks of age and persisting up to 1 year. TheJag1+/−Mfng+/− livers showed a subtle, yet significant increase in bile duct numbers and bile duct to portal tract ratios. These abnormalities were not observed in the newborn period. Despite the portal tract expansion by bile ducts, fibrosis was not increased and epithelial to mesenchymal transition was not shown in the affected portal tracts.Conclusion:Mice heterozygous for mutations inJag1and the Fringe genes display striking bile duct proliferation, which is not apparent at birth. These findings suggest that the Fringe genes may regulate postnatal bile duct growth and remodeling, and serve as candidate modifiers of the hepatic phenotype in AGS. (Hepatology 2008;48:1989–1997.)

Abbreviations: AGS, Alagille syndrome; Dll1, Delta-like 1; IHC, immunohistochemistry; Lfng, Lunatic Fringe; Rfng, Radical Fringe; Mfng, Manic Fringe.

Copyright © 2008 American Association for the Study of Liver Diseases.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid